康希诺：公司在按计划推进候选产品的研发工作

Core Viewpoint - The company is advancing its candidate product development as planned and will share updates on progress when available [1] Group 1: R&D Progress - The company is actively progressing its candidate product research and development [1] - Updates on any significant advancements will be communicated to stakeholders [1] Group 2: Business Expansion - The company is leveraging its mRNA platform to expand related business opportunities [1] - A three-component LNP delivery system has been authorized for external use and supports other partners in research and development [1] - The company is collaborating with domestic and international partners to further enhance the application and value of its platform [1]